Weekly Biotech Catalyst Watchlist 2-19-23

Last week hedge funds had to report their Q4 holdings, we analyzed 35+ biotech hedge funds to see what their favorite companies are, see the companies held by the most funds in the premium article. Last week we also saw TVTX get approval for their drug Sparsentan, check out all the upcoming March PDUFA's here. Looking forward, we still have a number of data readouts and PDUFA decisions coming in February. See catalysts coming this week/month in the table below!

Want to read more?

Subscribe to bpiq.com to keep reading this exclusive post.

Subscribe Now